characteristics.text: Y132F+G307A
characteristics.characteristic: Erg11 Genotype
characteristics.text: SAMN41569564
characteristics.characteristic: External Id
characteristics.text: W1370R
characteristics.characteristic: Fks1 Genotype
characteristics.text: Conway Institute, University College Dublin
characteristics.characteristic: INSDC center name
characteristics.text: 2024-05-28T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-05-28T13:01:11.960Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS21446506
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Pathogen.cl
characteristics.characteristic: NCBI submission model
characteristics.text: Pathogen.cl.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS21446506
characteristics.characteristic: SRA accession
characteristics.text: Ege University Hospital, Turkey
characteristics.characteristic: collected_by
characteristics.text: 2021-06-30
characteristics.characteristic: collection_date
characteristics.text: Turkey: Ege
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.characteristic: host
characteristics.text: Invasive candidiasis
characteristics.characteristic: host_disease
characteristics.text: A one-year-old male patient with past history of Hirschsprungs disease was admitted to EUH on August 17, 2020 for management of his bowel complications. The patient underwent three operationsbowel lengthening, jejunostomy, and ileostomyduring his hospitalization. Subsequently, he was hospitalized in the Pediatric Surgery Intensive Care Unit. During his hospitalization, bacteria (carbapenem-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus epidermidis) were recovered from his blood and urine cultures. He received broad-spectrum antibacterials, and prophylactic fluconazole. During a transfer to the pediatric intensive care unit, caspofungin was added empirically to the prophylactic fluconazole on June 21, 2021 (indication was not specified). C. parapsilosis was isolated from the patients urine and blood samples taken on June 26 and June 30, 2021, respectively, after which treatment with caspofungin was continued. Finally, the patient succumbed to infection on July 5, 2021.
characteristics.characteristic: isolate
characteristics.text: blood sample
characteristics.characteristic: isolation_source
characteristics.text: 38.4567 N 27.2099 E
characteristics.characteristic: lat_lon
characteristics.text: Candida parapsilosis
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_5480
characteristics.characteristic: organism
characteristics.text: MDR5
characteristics.characteristic: strain
characteristics.text: Pathogen: clinical or host-associated sample from Candida parapsilosis
characteristics.characteristic: title